A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/1997
11/06/1997	WO1997040829A1 Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy
11/06/1997	WO1997040679A1 Methods for delivering compounds into a cell
11/06/1997	WO1997035969A3 Peptide ligands of the urokinase receptor
11/06/1997	CA2253608A1 Therapeutic treatment for vegf related diseases
11/06/1997	CA2253433A1 Mammalian regulator of nonsense-mediated rna decay
11/06/1997	CA2253288A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, process for their production, intermediate products and use for the production of pharmaceutical agents
11/06/1997	CA2253263A1 Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
11/06/1997	CA2252869A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
11/06/1997	CA2252706A1 Polypeptide conjugates for transporting substances across cell membranes
11/06/1997	CA2252675A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
11/06/1997	CA2252617A1 Methods for delivering compounds into a cell
11/06/1997	CA2251813A1 5,6,7,8-tetrahydropyrido¬2,3-d\|pyrimidines
11/05/1997	EP0805203A1 The use of a substance which prevents HGS/SF from binding with Met
11/05/1997	EP0805162A1 Peptide determinant associated with immunity
11/05/1997	EP0805158A2 Halo-substituted protein kinase C inhibitors
11/05/1997	EP0804613A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins
11/05/1997	EP0804601A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
11/05/1997	EP0804596A1 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4
11/05/1997	EP0804585A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer
11/05/1997	EP0804581A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/05/1997	EP0804580A1 Calcium binding recombinant antibody against protein c
11/05/1997	EP0804562A1 Connective tissue growth factor-2
11/05/1997	EP0804487A2 Bispecific antigen-binding molecules
11/05/1997	EP0804483A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
11/05/1997	EP0804482A1 Cytokines that bind the cell surface receptor hek
11/05/1997	EP0804471A1 Gnrh antagonists
11/05/1997	EP0804468A1 Conformationally constrained backbone cyclized peptide analog
11/05/1997	EP0804466A1 Novel tetrapeptides, their manufacture and use
11/05/1997	EP0804463A1 Neurokinine (tachykinine) antagonists
11/05/1997	EP0804451A1 Lung cancer marker
11/05/1997	EP0804445A1 Metallocenic diarylethylene derivatives, methods for their preparation and pharmaceutical compositions containing same
11/05/1997	EP0804439A1 Beta, beta '-dihydroxy meso-substituted chlorins, isobacteriochlorins, bacteriochlorins, and methods for making the same from beta ,beta '-unsubstituted tetrapyrrolic macrocycles
11/05/1997	EP0804415A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same
11/05/1997	EP0804413A1 Nitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their production
11/05/1997	EP0804240A1 Compounds for preventing multidrug resistance in cancer cells containing protein kinase inhibitors
11/05/1997	EP0804231A1 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
11/05/1997	EP0804222A1 Accessory factor function for interferon gamma and its receptor
11/05/1997	EP0804218A1 Product and process for regulating signal transduction pathways
11/05/1997	EP0804217A2 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
11/05/1997	EP0804216A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
11/05/1997	EP0804212A2 $i(NIGELLA SATIVA) AS A MEDICINAL TREATMENT
11/05/1997	EP0804211A1 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria
11/05/1997	EP0804194A1 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
11/05/1997	EP0804177A1 Use of nitric oxide-releasing agents for reducing metastasis risk
11/05/1997	EP0607400B1 Fluorinated 17-beta substituted-4-aza-5-alpha- andostran-3one derivatives.
11/05/1997	CN1164234A Pyrrolo £2,3-d\| pyrimidines and their use
11/05/1997	CN1164194A Remedy for diseases caused by IL-6 production
11/05/1997	CN1164190A Cell growth regulator
11/05/1997	CN1163895A Novel prodrugs for therapy of tumors and inflammatory disorders
11/04/1997	US5684166 (-3-ketotetrahydrofuran-2-yl) ethanal derivatives and a method for their preparation
11/04/1997	US5684133 Neurite growth regulatory factors, antibodies thereto, and pharmaceutical compositions
11/04/1997	US5684036 Antitumor and anticarcinogenic agents
11/04/1997	US5684013 Farnesyl protein transferase
11/04/1997	US5684004 Antineoplastic agents, antiatherosclerotic agents, hypocholesterolemic agents
11/04/1997	US5683985 Oligonucleotide decoys and methods relating thereto
11/04/1997	US5683902 Human papilloma virus inhibition by a hairpin ribozyme
11/04/1997	US5683886 Tumor rejection antigens which correspond to amino acid sequences in tumor rejection antigen precursor bage, and uses thereof
10/1997
10/30/1997	WO1997040180A1 Chicken embryo lethal orphan (celo) virus
10/30/1997	WO1997040158A1 Epimorphin antagonist and process for producing the same
10/30/1997	WO1997040143A1 Apoptosis inducing protein and gene encoding the same
10/30/1997	WO1997040142A1 Modified ligands of calcium-dependent binding proteins
10/30/1997	WO1997040073A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS
10/30/1997	WO1997040069A2 Secreted proteins and polynucleotides encoding them
10/30/1997	WO1997040057A1 Antitumoral anthracycline disaccharides
10/30/1997	WO1997040031A1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
10/30/1997	WO1997040028A1 Urea derivatives as inhibitors of impdh enzyme
10/30/1997	WO1997040019A1 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick
10/30/1997	WO1997040012A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
10/30/1997	WO1997040006A2 Phosphate mimics
10/30/1997	WO1997039755A1 Oral pharmaceutical preparation containing ibandronat
10/30/1997	WO1997039749A2 Method for the prevention and treatment of cachexia and anorexia
10/30/1997	WO1997039748A1 Modulators of molecules with phosphotyrosine recognition units
10/30/1997	WO1997039721A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997	WO1997029779A3 EGF-Genistein conjugates for the treatment of cancer
10/30/1997	CA2252835A1 Chicken embryo lethal orphan (celo) virus
10/30/1997	CA2252778A1 Phosphate mimics
10/30/1997	CA2252643A1 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997	CA2252088A1 Secreted proteins and polynucleotides encoding them
10/30/1997	CA2250921A1 Modified ligands of calcium-dependent binding proteins
10/29/1997	EP0803505A1 Inhibitors of metalloproteases, process for their preparation and pharmaceutical compositions containing them
10/29/1997	EP0802985A1 Cell cycle regulated repressor and dna element
10/29/1997	EP0802924A1 Antibodies against t-cells as therapeutics
10/29/1997	EP0802921A1 Human pak65
10/29/1997	EP0802915A1 Camptothecin derivatives and its manufacturing method
10/29/1997	EP0802914A1 Aryl and heteroaryl purine compounds
10/29/1997	EP0802911A1 Hydrophobic taxane derivatives
10/29/1997	EP0802910A1 Estrogen agonists/antagonists
10/29/1997	EP0802908A1 Novel compounds
10/29/1997	EP0802902A1 Indole derivatives useful in the treatment of osteoporosis
10/29/1997	EP0802897A1 Novel compounds
10/29/1997	EP0802801A2 Methods and compositions for treatment of solid tumors in vivo
10/29/1997	EP0802799A1 BIOTHERAPY OF CANCER BY TARGETING TP-3/p80
10/29/1997	EP0802783A1 Topical preparations containing l-arginine
10/29/1997	EP0679154B1 New crystalline form of a vitamin d analogue
10/29/1997	EP0672063B1 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
10/29/1997	CN1163604A Substituted r-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
10/29/1997	CN1163270A Anti-hyerplasia and anti-inflammatory compound: pentose monosaccharide devivative
10/28/1997	US5681944 Hybridizes with the translation initiation region of the e6 or e7 messanger rna of human papilloma virus such that replication of virus is inhibited
10/28/1997	US5681940 Sugar modified nucleosides and oligonucleotides
10/28/1997	US5681863 Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors

1 ... 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 ... 2211